Ernest A. Carabillo

Ernest A. Carabillo

Nessuna posizione attualmente
Health Technology
Process Industries
Finance

Profilo

Mr. Carabillo is an internationally recognized authority on regulatory affairs and clinical and quality management issues.
Prior to Synogen, he was the founder and president of EXPERTech, a renowned FDA regulatory consulting group, and was Vice President of Corporate Regulatory and Quality Administration for Baxter Healthcare Corporation.
Prior to that, he was the management board member responsible for those activities at Dade Diagnostics, C.R.
Bard's Implant and Critical Care divisions, and the Medical Device and Pharmaceutical Divisions of Union Carbide.
In government, he served as the Associate Director for Regulatory Affairs of the office of Drug Abuse Policy in the executive office of the President, prior to which he held positions in the Department of Justice (DEA) and the Food and Drug Administration, serving as the Chief of three divisions.
He is admitted to the Supreme Court of the United States, and the New York State Bar.
He is also a Pharmacist.

Precedenti posizioni note di Ernest A. Carabillo

SocietàPosizioneFine
Investitore di Private Equity -
Direttore/Membro del Consiglio 13/10/2011
ALERE INC Direttore/Membro del Consiglio 02/04/2005
Corporate Officer/Principal -
Direttore Amministrativo -
Vedi nel dettaglio l'esperienza di Ernest A. Carabillo

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

5

Relazioni di 1° grado

5

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private5

Health Technology

Process Industries

Health Technology

Health Technology

Finance

  1. Mercati
  2. Insiders
  3. Ernest A. Carabillo
ULTIMI ORARI | -40%: I migliori strumenti riservati agli abbonati per identificare i migliori investimenti di domani!
g
:
:
ENTRA ORA